Angiotensin-converting enzyme insertion/deletion polymorphism and retinal artery occlusion

Acta Ophthalmol Scand. 2006 Jun;84(3):305-8. doi: 10.1111/j.1600-0420.2006.00656.x.

Abstract

Purpose: An insertion/deletion (I/D) polymorphism of the gene for angiotensin-converting enzyme (ACE) is associated with higher ACE plasma levels and activity. This enzyme is known to play an important role in blood pressure regulation and the ACE I/D gene polymorphism has been suggested as a risk factor for atherosclerotic vascular diseases. The purpose of the present study was to investigate a hypothesized association between the ACE I/D polymorphism and retinal artery occlusion (RAO).

Methods: A total of 159 patients with RAO and 304 control subjects were enrolled in the present retrospective case-control study. ACE I/D genotypes were determined by polymerase chain reaction.

Results: Allelic frequencies and genotype distribution of the ACE I/D polymorphism did not significantly differ between patients and control subjects (ACE DD 25.8% versus 28.0%; p = 0.36). A logistic regression analysis predicted the presence of RAO by arterial hypertension and current smoking status, but not by ACE I/D genotypes.

Conclusion: Our data suggest that the ACE I/D polymorphism is not a major risk factor for RAO.

MeSH terms

  • Aged
  • Case-Control Studies
  • DNA / genetics
  • Female
  • Gene Deletion*
  • Gene Frequency
  • Genotype
  • Humans
  • Hypertension / genetics
  • Male
  • Mutagenesis, Insertional / genetics*
  • Peptidyl-Dipeptidase A / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Retinal Artery Occlusion / enzymology
  • Retinal Artery Occlusion / genetics*
  • Retrospective Studies
  • Risk Factors
  • Smoking / genetics

Substances

  • DNA
  • Peptidyl-Dipeptidase A